The Interactions of Parasite Calreticulin With Initial Complement Components: Consequences in Immunity and Virulence
Galia Ramírez-Toloza1, Lorena Aguilar-Guzmán2, Carolina Valck3
1Department of Preventive Veterinary Medicine, Faculty of Veterinary Medicine and Livestock Sciences, University of Chile, Santiago, Chile.
Frontiers in Immunology
|August 15, 2020
Summary
Trypanosoma cruzi calreticulin (TcCalr) inhibits key pathways of the complement system, aiding parasite survival. Understanding this interaction may lead to new therapies for Chagas disease.
Area of Science:
- Immunology
- Parasitology
- Molecular Biology
Background:
- The complement system is vital for innate and adaptive immunity.
- Pathogens often evade complement via regulatory proteins.
- Trypanosoma cruzi causes Chagas disease and employs virulence factors to inhibit complement.
Purpose of the Study:
- To investigate the role of Trypanosoma cruzi calreticulin (TcCalr) in inhibiting the complement system.
- To elucidate the mechanisms by which TcCalr interferes with complement activation pathways.
- To explore the implications of TcCalr's complement interaction for parasite infectivity and potential therapeutic strategies.
Main Methods:
- The study focuses on the interaction between TcCalr and complement components.
- Investigated the inhibition of classical and lectin complement pathways by TcCalr.
- Examined the role of the TcCalr/C1 interaction in parasite infectivity.
Main Results:
- TcCalr inhibits the classical and lectin complement pathways by binding C1, MBL, and ficolins.
- The TcCalr/C1 interaction facilitates parasite infectivity by mimicking apoptotic cell clearance.
- Similar calreticulin strategies are employed by various other parasites.
Conclusions:
- TcCalr is a significant virulence factor for Trypanosoma cruzi, effectively inhibiting complement activation.
- The molecular mimicry employed by TcCalr represents a conserved parasitic strategy for immune evasion.
- Further research into TcCalr-complement interactions could yield novel anti-parasitic therapies and prophylaxis for Chagas disease.
More Related Videos
Related Concept Videos
Complement System
8.2K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
8.2K
Antimicrobial Proteins
12.7K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
12.7K
Cell-mediated Immune Responses
82.6K
Overview
82.6K
Calmodulin-dependent Signaling
5.8K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.8K


